Varian Sustainability Profile
Varian Medical Systems, commonly referred to as Varian, is a leading player in the healthcare technology sector, headquartered in the United States. Founded in 1948, the company has established itself as a pioneer in radiation oncology, providing innovative solutions for cancer treatment. With a strong presence in North America, Europe, and Asia, Varian focuses on advanced medical devices and software that enhance cancer care. The company’s core offerings include radiotherapy systems, software for treatment planning, and comprehensive patient management solutions. Varian's commitment to precision and efficiency sets its products apart in the competitive landscape. Recognised for its contributions to the field, Varian has achieved significant milestones, including the development of cutting-edge technologies that improve patient outcomes. As a trusted name in oncology, Varian continues to shape the future of cancer treatment globally.
DitchCarbon Score
How does Varian's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Metal Fabrication industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Varian's score of 40 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Varian's reported carbon emissions
In 2018, Varian Medical Systems, Inc. reported total carbon emissions of approximately 606,554,000 kg CO2e, with emissions distributed across various scopes: 21,486,000 kg CO2e (Scope 1), 9,029,000 kg CO2e (Scope 2), and a significant 576,039,000 kg CO2e (Scope 3). The Scope 3 emissions were primarily driven by purchased goods and services (293,779,890 kg CO2e) and the use of sold products (120,968,190 kg CO2e). Varian has set ambitious reduction targets, aiming to decrease its carbon footprint by a minimum of 25% from a 2010 baseline by 2020 for both Scope 1 and Scope 2 emissions. This commitment reflects the company's proactive approach to mitigating its greenhouse gas emissions. As a current subsidiary of Siemens Healthineers AG, Varian's climate initiatives and performance data are cascaded from its parent company. The emissions data and reduction targets are part of Varian's broader commitment to sustainability and climate responsibility within the healthcare technology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2017 | 2018 | |
|---|---|---|---|
| Scope 1 | 26,723,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 17,315,000 | 0,000,000,000 | 0,000,000 |
| Scope 3 | 443,845,000 | - | 000,000,000 |
How Carbon Intensive is Varian's Industry?
How Carbon Intensive is Varian's Location?
Varian's Scope 3 Categories Breakdown
Varian's Scope 3 emissions, which increased by 30% last year and increased by approximately 30% since 2015, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 51% of Scope 3 emissions.
Top Scope 3 Categories
Varian's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Varian has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
